Based in Washington, D.C., MASA Life Science Ventures focuses on investing in private, high-growth bio-technology and life science companies during Series A through B and seed rounds. They have made four investments, including Apellis Pharmaceuticals, Cytox, and MediQuest Therapeutics, and have helped raise funds ranging from $700k to $23 million. With offices in Washington, Tokyo, and Seoul, MASA Inc. provides comprehensive financial and technology consulting services and specializes in private equity transactions in various regions.